About Corgenix
Corgenix is a Healthcare company based in Broomfield (United States) founded in 1990, and was acquired by Orgentec Diagnostika in August 2014. Diagnostic tests for vascular diseases are developed and supplied. The company has 24 employees. Its chief executive, as recorded, is Werner Hofacher. Corgenix offers products and services including M-inSight® and Diagnostic Solutions. Its focus areas include Biopharma Outsourcing, CRO, Diversified and Life Sciences. Its competitors include Charles River Laboratories, Cytel and LabCorp; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1990, Corgenix is headquartered in Broomfield, United States. Focus is placed on the healthcare sector, where in vitro diagnostic tests for vascular diseases are created and distributed. Operations involve research, manufacturing, and commercialization of these medical products to support clinical applications. Leadership is provided by CEO Werner Hofacher, with activities centered in the United States market.
- Headquarters Broomfield, United States
- Employees 24
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website corgenix.com
- Social LinkedIn X
- Acquired by Orgentec Diagnostika (Aug 2014)
- InvestorsHHS
& 2 more
- Employee Count24
- Acquired byOrgentec Diagnostika
(Aug 2014)
Products & Services of Corgenix
Corgenix offers a comprehensive portfolio of products and services, including M-inSight® and Diagnostic Solutions.
Test for monitoring multiple myeloma patients in clinical settings
Services for clinical studies and trial management support
Funding Insights of Corgenix
- Total Rounds 5
- First Round $1M
(Sep 2007)
- Investors Count 2
All 5 funding rounds of Corgenix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2014 | Grant | – | – | ||
| Jul 2010 | $1.25M | Post-IPO | – | – | – |
| Apr 2010 | $3.58M | Grant | – | – | |
| Mar 2010 | $590,176 | Grant | – | – | |
| Sep 2007 | $1M | Post-IPO | – | – | – |
3 investors in total: 3 institutional.
Investors in Corgenix
Corgenix has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include HHS, European Union and Orgentec Diagnostika.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Diagnostics tools for Autoimmune and Infectious Diseases | 2009 | orgentec.com | Mainz, Germany |
Investor details for Corgenix
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Corgenix
1 people are tracked at Corgenix (1 in leadership); the tracked headcount is 24.
| Name | Role | Group |
|---|---|---|
Werner Hofacher | CEO | Leadership |
Complete people profiles for Corgenix
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Corgenix
5 dated milestones of Corgenix across 24 years, from founding to its latest funding, stage changes and deals.
- Founded Corgenix is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $1.0M.
- Funding Latest funding round, Grant,.
- Exit Acquired by Orgentec Diagnostika.
Competitors of Corgenix
Corgenix has 3 listed competitors in our database, 1 of them funded. They include Charles River Laboratories, Cytel and LabCorp.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| criver.com | 1947 | Wilmington, United States | 21,400 | Provider of drug discovery and preclinical development services | ||
| cytel.com | 1987 | Cambridge, United States | $2M | 509 | Data analysis and statistical solutions are provided for life sciences. | |
| labcorp.com | 1969 | Burlington, United States | 9,321 | Provider of laboratory tests for physicians |
Detailed competitors of Corgenix
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Corgenix
The website of Corgenix (corgenix.com) receives about 2.4K visits a month.
- Monthly visits2.4K
▲ 116.1% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Corgenix (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Corgenix
Complete news archive for Corgenix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Corgenix
Corgenix was founded in 1990 and raised its 1st funding round 17 years after it was founded.
Corgenix is headquartered in Broomfield, United States. It is registered at Broomfield, Colorado, United States.
Werner Hofacher is the CEO of Corgenix, as recorded in our data.
Corgenix has 24 employees.
Founded in 1990, Corgenix is headquartered in Broomfield, United States. Focus is placed on the healthcare sector, where in vitro diagnostic tests for vascular diseases are created and distributed. Operations involve research, manufacturing, and commercialization of these medical products to support clinical applications. Leadership is provided by CEO Werner Hofacher, with activities centered in the United States market.
Corgenix's top competitors include LabCorp, Charles River Laboratories and Cytel.
Corgenix offers M-inSight® and Diagnostic Solutions.
Corgenix has 3 investors. Key investors include HHS, European Union, and Orgentec Diagnostika.
Yes. Corgenix was acquired by Orgentec Diagnostika in August 2014.